Your new experience awaits. Try the new design now and help us make it even better

PERSPECTIVE article

Front. Child Adolesc. Psychiatry, 13 October 2025

Sec. Autism and Other Neurodevelopmental Disorders

Volume 4 - 2025 | https://doi.org/10.3389/frcha.2025.1682129

Rethinking self-identification in neurodivergent communities: barriers, harms, and the need for change


Alice NewtonAlice Newton1Aidan Flinn
Aidan Flinn2*James DownsJames Downs3Laura Richmond
Laura Richmond4
  • 1Manchester University NHS Foundation Trust, Manchester, United Kingdom
  • 2Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biological, Medical and Health Sciences, Manchester Academic Health Science, University of Manchester, Manchester, United Kingdom
  • 3Independent Researcher, Cardiff, United Kingdom
  • 4Department of Clinical, Education and Health Psychology, University College London, London, United Kingdom

Self-identification of neurodivergence is increasingly common, yet remains contentious in psychiatric, medical, and public discourse. While concerns have been raised about the reliability and potential impact on clinical services, these discussions often neglect the systemic barriers and personal experiences that can lead to self-identification in the first place. This article explores why individuals might self-identify, highlighting inequities in diagnostic access and clinician biases, as well as individual experiences and beliefs around clinical diagnosis. We argue that while self-identification can be a personal preference, it is often a survival strategy in the face of inaccessible, exclusionary, and sometimes harmful diagnostic systems. Drawing on theories of epistemic justice, we critique medical gatekeeping that delegitimises self-identification and propose a shift towards neurodiversity-affirming care. Rather than policing self-identification, we suggest that efforts should be made to address structural failures that render it necessary. Until access to clinical diagnosis become equitable, self-identification will remain an essential and legitimate means of understanding neurodivergence.

1 Introduction

Conversations around neurodivergence and self-diagnosis are increasingly prevalent, as more people begin to identify as neurodivergent without—or prior to—clinical diagnosis. This shift has sparked debate within psychiatric, medical, and public discourse, with concerns raised about the validity of self-diagnosis, its implications for clinical services, and its potential impact on how neurodivergence is understood and supported (1). Discussions around self-diagnosis can often overlook the lived experiences of those who identify and are diagnosed as neurodivergent, as well as the barriers and systemic factors that lead to self-identification. Self-identification of neurodivergence is a legitimate expression of an identity shaped through a social rather than a medical lens and is an essential part of understanding the way an individual may perceive and experience the world. This has been shown to improve self-understanding and self-acceptance (25). As such, in this article, we explore the barriers and personal viewpoints that make self-identification essential for so many neurodivergent individuals, the harms perpetuated by exclusionary diagnostic processes, and the importance of shifting towards more inclusive, neuro-affirmative models of care (see Figure 1).

Figure 1
Flowchart depicting a process starting with \

Figure 1. Routes to understanding and support for neurodivergent individuals.

We write from the perspective of neurodivergent individuals, both self-identified and formally diagnosed. We prefer the term “self-identification” over “self-diagnosis” because it reflects a recognition of neurodivergence that does not necessarily rely on a medical model. Many of us do not see neurodivergence as an illness or deficit, and self-identification can be a meaningful, legitimate, and necessary means of understanding ourselves and the world. While our identities are by no means heterogenous, we acknowledge that as white British people who have been able to access higher education, we carry privileges which may obscure experiences of other neurodivergent individuals. Nonetheless, we offer our own views and experiences to balance the points made by others in the field related to self-identification, we highlight significant problems in the provision of timely, appropriate healthcare, and we present an alternative point of view based on our lived experiences. The views, language and terminology expressed in this paper are appropriate at the time of writing, but this may change as our understanding advances.

2 Background

2.1 Barriers to clinical diagnosis

2.1.1 Obtaining a referral to a specialist service

In the UK, the first step to pursuing a clinical diagnosis of neurodivergence, such as Autism or ADHD, is to see your general practitioner [GP; (6)]. This often begins with scheduling and attending some form of appointment: even at this very early stage there may already be multiple barriers present for certain populations. Doherty et al. (7) found that 80% of autistic adults in their study had difficulty attending GP appointments, which drops to 37% for the non-autistic adults. Some of the reasons provided by autistic adults around why they found visiting the GP difficult were: not feeling understood, difficulty communicating with their doctor and the waiting room environment (7).

When it comes to attending an appointment and exploring a referral to specialist services, success can depend on the education, approach and confidence of the GP or clinician. One study found that 39.4% of GP's reported having received no formal training around autism and many GPs reported struggling with their confidence in their ability to identify and provide support to autistic people (6). People exploring whether they are autistic have reported concerns around their GP's knowledge and understanding of autism, which is often a source of stress during the process (8). Other research has found similar outcomes when it comes to ADHD, with both service users and GP's reporting that whilst GP's had some knowledge of ADHD, most GPs had limited understanding and obtaining a referral to specialist services usually relied on the individual already having a strong idea that they might have ADHD (9). This highlights an important issue: even if a clinical diagnosis is sought out and given, some element of self-identification can predate it.

Another potential barrier to obtaining a referral to a specialist service is clinician bias. As the clinician acts as a gatekeeper to specialist services, a referral relies on their perceptions and opinion. For example, research as highlighted significant racial biases in the referral and assessment process, leading to misidentification and exclusion of people from ethnic minority communities (10, 37). Despite this, GPs have consistently expressed their desire to learn and provide a better service for neurodivergent individuals, further highlighting the need for further understanding and training opportunities (6, 9).

2.1.2 Diagnostic assessments

NHS diagnostic services are severely under-resourced, with waiting times to see specialist teams varying dramatically depending on location. Data from the UK shows that a person seeking an ADHD assessment might wait 12 weeks in one part of the country and over 10 years in another (11). By the time an individual joins a waiting list, they may have already spent years questioning their experiences and seeking answers. Faced with yet another long wait, many understandably turn to self-identification to make sense of their identity, find communities, and access the support they need.

Another difficulty within the diagnostic process can be a failure to account for adaptive strategies neurodivergent individuals use to “pass” as neurotypical. Recent research has highlighted that masking could be a key reason why many neurodivergent people do not receive a clinical diagnosis, particularly in childhood (12). Masking, which is also sometimes termed social camouflaging, is the act of trying to disguise and compensate for neurodivergent traits in an effort to cope in a predominantly neurotypical social world (13, 14). It is important to note that masking often comes at a great cost to the individual. Masking can increase psychological distress and exhaustion (15, 16). The process of learning not to mask is often a long and difficult one fraught with lots of emotions (17), it might be difficult for someone to immediately unmask, or even identify what constitutes their mask, for an appointment with someone they have never met before.

Clinician bias can also affect the outcome of a diagnostic assessment. Research has shown that children from minoritised ethnic backgrounds are less likely than white children to receive an ADHD diagnosis (1820) and are more likely to be misdiagnosed with “conduct disorders” instead (21). Women and people of marginalised genders face similar barriers, with outdated assumptions about “typical” presentations leading to frequent misdiagnosis with personality disorders or other mental health conditions (16, 22). These biases create a self-perpetuating cycle in which certain groups are underdiagnosed, reinforcing a narrow and exclusionary view of neurodivergence. These concerns deter people from seeking out a clinical diagnosis alongside as making the process of assessment more challenging for both the assessor and the person being assessed.

2.1.3 Choosing not to pursue clinical diagnosis

There are people who choose not to pursue clinical diagnosis due to the fear of possible social, personal, or professional repercussions. Concerns can range from losing opportunities such as the ability to emigrate, to being treated differently by peers (23, 24). These concerns have been validated by recent research with Stagg and Belcher (25), reporting that adults who received a clinical diagnosis of autism in later life reported difficult consequences, including one participant losing a job due to discrimination. Thus, it is understandable that some people may be deterred from seeking a clinical diagnosis.

There are a proportion of people who may reject engaging with clinical care due to difficult past experiences and fear of mistreatment/harm from clinical services. Aves (26) critiques how distress in neurodivergent individuals can be misinterpreted by clinicians. For example, autistic distress responses—which may involve shutdowns, intense emotional reactions, or withdrawal—are often mislabelled as “manipulative” or “attention-seeking”, rather than understood as valid expressions of overwhelm. Brede et al. (27) documented cases where autistic women were dismissed by clinicians, with some explicitly told that they were “too articulate” or “too socially competent” to be autistic. This misinterpretation could result in inappropriate interventions or diagnoses, including coercive treatments and invalidating responses. Similarly, autistic distress can be misread as symptoms of mental illness, resulting in inappropriate use of medication, misdiagnosis, and even psychiatric hospitalisation, shown in multiple case studies (28, 29). These experiences can lead to deep mistrust of healthcare providers and avoidance of services, with neurodivergent people relying instead on self-identification and community support. In this context, self-identification is not an act of defiance but one of self-preservation.

Another important factor in the decision not to pursue a clinical diagnosis can be the ways in which the medical model can pathologize neurodivergence (24). The medical model often uses deficit-based language, for example, categorising traits as impairments rather than valid ways of being. This can alienate individuals who see their neurodivergence as an identity rather than a disorder. As a result, some people may reject clinical diagnosis in favour of self-identification, as this may offer a more accurate and affirming understanding of their experiences.

3 Discussion

Self-identification can have a myriad of benefits for neurodivergent people. Many neurodivergent people have spent years, sometimes decades, feeling different but unable to explain why (25). Neurodivergent people report that self-identification can lead to a greater understanding one's experiences, challenges, and strengths, often leading to increased self-compassion and acceptance (24, 30). We believe that every neurodivergent person has a right to these benefits, whether they can access a clinical diagnosis or not.

One perceived difficulty with self-identification is that it may limit the types of support someone can access for example, medication for ADHD or access to post-diagnostic support. However, at present, post-diagnostic support varies enormously between services, and some teams do not provide any post-diagnostic support. Subsequently, it has been suggested that clinical diagnosis can represent a false hope for getting support and solutions (24). While a clinical diagnosis may increase a person's access to support and accommodations, it is not legally required for accommodations to be made, and these can be at the discretion of an employer (31, 32). There are also types of support that can be accessed without a clinical diagnosis, such as online communities and some peer support groups.

Some critics argue that the increase in people self-identifying neurodivergence risks ‘diluting’ neurodivergent diagnoses (1). However, we posit that this perspective fails to acknowledge the rigid gatekeeping that prevents many from obtaining a diagnosis in the first place. Neurodivergent people are not responsible for ensuring that clinicians take them seriously—clinicians should take all patients seriously, regardless of whether they gain their understanding of themselves through self-identification or clinical assessment.

Another criticism of self-identification often presented is the concern that self-identification is inaccurate, in part due to the lack of training the individual has had compared with a professional (1, 33). No matter whether a person receives a clinical diagnosis or self-identifies, there will always be times where it may be judged by either themselves or someone else as inaccurate. However, this could happen with any physical or mental health condition. Diagnostic errors occur in medical settings as well (34). When it comes to neurodivergence, however, this is used as an argument against self-identification. It is worth considering such views might be due to attitudes towards neurodivergence in general, not just self-identification.

4 Conclusion

The numerous barriers to obtaining a clinical diagnosis mean that self-identification can be the only available pathway for neurodivergent individuals, especially those from minoritised backgrounds. When formal systems fail to recognise or understand neurodivergence, individuals are left to seek alternative means of understanding themselves—whether through online communities, self-reflection, or peer-led initiatives. Despite well-documented barriers to clinical diagnosis, those who self-identify are frequently met with scepticism and dismissal. Addressing these biases requires a fundamental shift in how neurodivergence is understood and assessed, moving away from deficit-based models that reinforce existing inequalities and towards neurodiversity-affirming frameworks that recognise the validity of lived experience and acknowledge people's ability to be the judge of their own experiences.

At the heart of debates about self-identification is often a question of power: who gets to define neurodivergence, and whose knowledge is considered legitimate? Historically, clinical expertise has been privileged over lived experience, with medical gatekeeping determining who is recognised as neurodivergent. Self-identification is often dismissed because it challenges traditional models of clinical authority. However, this dismissal is itself a form of epistemic injustice—a concept describing how certain groups are systematically disbelieved or denied credibility. Rather than treating self-identification as a “lesser” form of knowledge, it should be viewed as an essential component of a neurodiversity-affirming model of care.

Reforming diagnostic systems is necessary, but it is not enough. A truly inclusive model of neurodivergence must move beyond deficit-based frameworks toward approaches that value neurodivergent ways of being as valid expressions of humanity. The “double empathy problem” (38) highlights that the communication breakdown between neurodivergent and neurotypical people is mutual, not a deficit within neurodivergent individuals. This challenges traditional diagnostic approaches that assume neurodivergent communication styles are inherently “impaired” rather than differently structured. Neurodiversity-affirming care models, such as those proposed by Monique Botha, advocate for moving away from rigid diagnostic criteria and toward individualised, strengths-based approaches. These models align with co-production principles, which have been increasingly emphasised in policy—but rarely implemented effectively. Whilst the inclusion of neurodivergent voices is already mandated in mental health research (35) and service design (36), there is little evidence that these commitments have led to meaningful change.

The rise in self-identification among neurodivergent individuals is not a crisis—it is a response to crisis. Instead of viewing self-identification as a threat, we should recognise it as a response to systemic failures and an opportunity for change. Diagnosis remains an essential tool for many, but it is not the only valid means of understanding neurodivergence. Given the barriers, biases, and harms embedded in current diagnostic frameworks, self-identification can be an act of self-preservation and of epistemic resistance. Rather than policing self-identification, the focus should be on addressing the systemic barriers that render it necessary. A system that truly values neurodivergent perspectives must move beyond gatekeeping and deficit models toward approaches that centre self-knowledge, lived experience, and community validation. Until formal diagnostic systems are reformed to be equitable, affirming, and accessible, self-identification will remain a crucial—and entirely legitimate—pathway for recognising neurodivergence.

5 Clinical recommendations

We posit a range of clinical recommendations for practitioners who wish to incorporate self-identification into their practice. These are both attitudinal and practical, recognising the role that affirming and coproduced approaches play in creating more effective and equitable care:

• Adopt a neurodivergent-affirming stance: Approach self-identification as a valid and valuable expression of lived experience, rather than as a deficit or barrier to care. Actively welcome and encourage conversations about self-identification as part of a person-centred approach. (or similar!)

• Embed coproduction: Ensure that a diverse range of neurodivergent people have a meaningful role in designing, delivering, and evaluating the services they need and that lived experiences shape assessment pathways and clinical practice.

• Provide neurodivergent-led training to equip healthcare professionals (including referrers) with knowledge and confidence to support self-identifying neurodivergent individuals.

• Embed self-identification in referral and assessment: Ensure referrals and assessments capture the individual's own understandings and experiences of self-identification, alongside clinical perceptions. The diagnostic process should be undertaken in partnership with service users, not done to them or on them.

• Support community connection: Develop social prescribing, peer networks, caregiver support, and links with neurodivergent groups across diverse communities.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author contributions

AN: Writing – original draft, Project administration, Conceptualization, Writing – review & editing. AF: Conceptualization, Writing – original draft, Funding acquisition, Project administration, Writing – review & editing. JD: Writing – review & editing, Conceptualization, Project administration, Writing – original draft. LR: Conceptualization, Project administration, Writing – review & editing, Writing – original draft.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. The University of Manchester provided funding for publication using the Open Access Fund for unfunded authors.

Acknowledgments

The author's would like to thank the University of Manchester for providing the publication funding for this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issue please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. David AS, Deeley Q. Dangers of self-diagnosis in neuropsychiatry. Psychol Med. (2024) 54(6):1057–60. doi: 10.1017/S0033291724000308

PubMed Abstract | Crossref Full Text | Google Scholar

2. Overton GL, Marsà-Sambola F, Martin R, Cavenagh P. Understanding the self-identification of autism in adults: a scoping review. Rev J Autism Dev Disord. (2024) 11(4):682–702. doi: 10.1007/s40489-023-00361-x

Crossref Full Text | Google Scholar

3. Morrison KE, DeBrabander KM, Faso DJ, Sasson NJ. Variability in first impressions of autistic adults made by neurotypical raters is driven more by characteristics of the rater than by characteristics of autistic adults. Autism. (2019) 23(7):1817–29. doi: 10.1177/1362361318824104

PubMed Abstract | Crossref Full Text | Google Scholar

4. Lewis LF. Exploring the experience of self-diagnosis of autism spectrum disorder in adults. Arch Psychiatr Nurs. (2016) 30(5):575–80. doi: 10.1016/j.apnu.2016.03.009

PubMed Abstract | Crossref Full Text | Google Scholar

5. Parsloe SM. Discourses of disability, narratives of community: reclaiming an autistic identity online. J Appl Commun Res. (2015) 43(3):336–56. doi: 10.1080/00909882.2015.1052829

Crossref Full Text | Google Scholar

6. Unigwe S, Buckley C, Crane L, Kenny L, Remington A, Pellicano E. GPs’ confidence in caring for their patients on the autism spectrum: an online self-report study. Br J Gen Pract. (2017) 67:e445–52. doi: 10.3399/bjgp17X690449

PubMed Abstract | Crossref Full Text | Google Scholar

7. Doherty M, Neilson S, O’Sullivan J, Carravallah L, Johnson M, Cullen W, et al. Barriers to healthcare and self-reported adverse outcomes for autistic adults: a cross-sectional study. BMJ Open. (2022) 12(2):e056904. doi: 10.1136/bmjopen-2021-056904

PubMed Abstract | Crossref Full Text | Google Scholar

8. Crane L, Batty R, Adeyinka H, Goddard L, Henry LA, Hill EL. Autism diagnosis in the United Kingdom: perspectives of autistic adults, parents and professionals. J Autism Dev Disord. (2018) 48(11):3761–72. doi: 10.1007/s10803-018-3639-1

PubMed Abstract | Crossref Full Text | Google Scholar

9. French B, Perez Vallejos E, Sayal K, Daley D. Awareness of ADHD in primary care: stakeholder perspectives. BMC Fam Pract. (2020) 21(1):45. doi: 10.1186/s12875-020-01112-1

PubMed Abstract | Crossref Full Text | Google Scholar

10. Straiton D, Sridhar A. Call to action for autism clinicians in response to anti-black racism. Autism. (2022) 26(4):988–94. doi: 10.1177/13623613211043643

PubMed Abstract | Crossref Full Text | Google Scholar

11. Royal College of Psychiatrists. Latest NHS data shows sharp rise in waiting times for first autism appointment. www.rcpsych.ac.uk. Available online at: https://www.rcpsych.ac.uk/news-and-features/latest-news/detail/2023/12/15/latest-nhs-data-shows-sharp-rise-in-waiting-times-for-first-autism-appointment (Accessed September 20, 2025).

Google Scholar

12. Hull L, Levy L, Lai M-C, Petrides K, Baron-Cohen S, Allison C, et al. Is social camouflaging associated with anxiety and depression in autistic adults? Mol Autism. (2021) 12(1):13. doi: 10.1186/s13229-021-00421-1

PubMed Abstract | Crossref Full Text | Google Scholar

13. Evans JA, Krumrei-Mancuso EJ, Rouse SV. What you are hiding could be hurting you: autistic masking in relation to mental health, interpersonal trauma, authenticity, and self-esteem. Autism in Adulthood. (2024) 6(2):229–40. doi: 10.1089/aut.2022.0115

PubMed Abstract | Crossref Full Text | Google Scholar

14. Cook J, Hull L, Crane L, Mandy W. Camouflaging in autism: a systematic review. Clin Psychol Rev. (2021) 89:102080. doi: 10.1016/j.cpr.2021.102080

PubMed Abstract | Crossref Full Text | Google Scholar

15. Beck JS, Lundwall RA, Gabrielsen T, Cox JC, South M. Looking good but feeling bad: “camouflaging” behaviors and mental health in women with autistic traits. Autism. (2020) 24(4):809–21. doi: 10.1177/1362361320912147

PubMed Abstract | Crossref Full Text | Google Scholar

16. Bargiela S, Steward R, Mandy W. The experiences of late-diagnosed women with autism spectrum conditions: an investigation of the female autism phenotype. J Autism Dev Disord. (2016) 46(10):3281–94. doi: 10.1007/s10803-016-2872-8

PubMed Abstract | Crossref Full Text | Google Scholar

17. Harrison S. Square pegs in disguise: exploring the impact of masking on autistic women’s mental health: trinity western university (Phd thesis). Trinity Western University (2025).

Google Scholar

18. Yang KG, Flores MW, Carson NJ, Cook BL. Racial and ethnic disparities in childhood ADHD treatment access and utilization: results from a national study. Psychiatr Serv. (2022) 73(12):1338–45. doi: 10.1176/appi.ps.202100578

PubMed Abstract | Crossref Full Text | Google Scholar

19. Shi Y, Guevara LRH, Dykhoff HJ, Sangaralingham LR, Phelan S, Zaccariello MJ, et al. Racial disparities in diagnosis of attention-deficit/hyperactivity disorder in a US national birth cohort. JAMA Netw Open. (2021) 4(3):e210321. doi: 10.1001/jamanetworkopen.2021.0321

PubMed Abstract | Crossref Full Text | Google Scholar

20. Coker TR, Elliott MN, Toomey SL, Schwebel DC, Cuccaro P, Tortolero Emery S, et al. Racial and ethnic disparities in ADHD diagnosis and treatment. Pediatrics. (2016) 138(3):138–56. doi: 10.1542/peds.2016-0407

Crossref Full Text | Google Scholar

21. Obeid R, Bisson JB, Cosenza A, Harrison AJ, James F, Saade S, et al. Do implicit and explicit racial biases influence autism identification and stigma? An implicit association test study. J Autism Dev Disord. (2021) 51(1):106–28. doi: 10.1007/s10803-020-04507-2

PubMed Abstract | Crossref Full Text | Google Scholar

22. Watts J. Engendering misunderstanding: autism and borderline personality disorder. Int J Psychiatry Clin Pract. (2023) 27(3):316–7. doi: 10.1080/13651501.2023.2187843

PubMed Abstract | Crossref Full Text | Google Scholar

23. Ardeleanu K, Steinberg H, Garfield T, Voltaire S, Shea L, Brown M, et al. Self-identification of autism: why some autistic adults lack a clinical diagnosis and why this matters for inclusion. Autism. (2025) 29(9):2344–55. doi: 10.1177/13623613241297222

PubMed Abstract | Crossref Full Text | Google Scholar

24. Friedman A, Paltoglou A, Sorte R. A qualitative exploration of the experiences of self-diagnosed autistic women and gender-diverse individuals who are not pursuing an autism diagnosis. Neurodiversity. (2024) 2:27546330241307828. doi: 10.1177/27546330241307828

Crossref Full Text | Google Scholar

25. Stagg SD, Belcher H. Living with autism without knowing: receiving a diagnosis in later life. Health Psychol Behav Med. (2019) 7(1):348–61. doi: 10.1080/21642850.2019.1684920

PubMed Abstract | Crossref Full Text | Google Scholar

26. Aves W. Escaping iatrogenic harm: a journey into mental health service avoidance. J Psychiatr Ment Health Nurs. (2024) 31:668–73. doi: 10.1111/jpm.13020

PubMed Abstract | Crossref Full Text | Google Scholar

27. Brede J, Cage E, Trott J, Palmer L, Smith A, Serpell L, et al. “We have to try to find a way, a clinical bridge”-autistic adults’ experience of accessing and receiving support for mental health difficulties: a systematic review and thematic meta-synthesis. Clin Psychol Rev. (2022) 93:102131. doi: 10.1016/j.cpr.2022.102131

PubMed Abstract | Crossref Full Text | Google Scholar

28. Luciano CC, Keller R, Politi P, Aguglia E, Magnano F, Burti L, et al. Misdiagnosis of high function autism spectrum disorders in adults: an Italian case series. Autism. (2014) 4(2):1–8. doi: 10.4172/2165-7890.1000131

Crossref Full Text | Google Scholar

29. Palucka AM, Bradley E, Lunsky Y. A case of unrecognized intellectual disability and autism misdiagnosed as schizophrenia: are there lessons to be learned? Mental Health Aspects Dev Disab. (2008) 11(2):55.

Google Scholar

30. Lewis LF. A mixed methods study of barriers to formal diagnosis of autism spectrum disorder in adults. J Autism Dev Disord. (2017) 47(8):2410–24. doi: 10.1007/s10803-017-3168-3

PubMed Abstract | Crossref Full Text | Google Scholar

31. Davies J, Heasman B, Livesey A, Walker A, Pellicano E, Remington A. Autistic adults’ views and experiences of requesting and receiving workplace adjustments in the UK. PLoS One. (2022) 17(8):e0272420. doi: 10.1371/journal.pone.0272420

PubMed Abstract | Crossref Full Text | Google Scholar

32. ACAS. Adjustments for Neurodiversity - Reasonable Adjustments at Work - Acas. London: Acas (2025). Available online at: https://www.acas.org.uk/reasonable-adjustments/adjustments-for-neurodiversity (Accessed September 13, 2025).

Google Scholar

33. Fellowes S. Establishing the accuracy of self-diagnosis in psychiatry. Philos Psychol. (2025) 38(6):2542–69. doi: 10.1080/09515089.2024.2327823

Crossref Full Text | Google Scholar

34. Cheraghi-Sohi S, Holland F, Singh H, Danczak A, Esmail A, Morris RL, et al. Incidence, origins and avoidable harm of missed opportunities in diagnosis: longitudinal patient record review in 21 English general practices. BMJ Qual Saf. (2021) 30(12):977–85. doi: 10.1136/bmjqs-2020-012594

PubMed Abstract | Crossref Full Text | Google Scholar

35. Jones N, Atterbury K, Byrne L, Carras M, Brown M, Phalen P. Lived experience, research leadership, and the transformation of mental health services: building a researcher pipeline. Psychiatr Serv. (2021) 72(5):591–3. doi: 10.1176/appi.ps.202000468

PubMed Abstract | Crossref Full Text | Google Scholar

36. Norton M. Implementing co-production in traditional statutory mental health services. Mental Health Pract. (2024) 27(1):e1304–16. doi: 10.7748/mhp.2019.e1304

Crossref Full Text | Google Scholar

37. Slade G. Diverse Perspectives: The Challenges for Families Affected by Autism from Black, Asian and Minority Ethnic Communities. London: The National Autistic Society (2014).

Google Scholar

38. Milton DE. On the ontological status of autism: the ‘double empathy problem’. Disabil Soc. (2012) 27(6):883–7. doi: 10.1080/09687599.2012.710008

Crossref Full Text | Google Scholar

Keywords: autism, ADHD, neurodivergence, self-diagnosis, self-identity

Citation: Newton A, Flinn A, Downs J and Richmond L (2025) Rethinking self-identification in neurodivergent communities: barriers, harms, and the need for change. Front. Child Adolesc. Psychiatry 4:1682129. doi: 10.3389/frcha.2025.1682129

Received: 8 August 2025; Accepted: 29 September 2025;
Published: 13 October 2025.

Edited by:

Maria Pia Riccio, Federico II University Hospital, Italy

Reviewed by:

Luca Steardo Jr, University Magna Graecia of Catanzaro, Italy

Copyright: © 2025 Newton, Flinn, Downs and Richmond. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Aidan Flinn, QWlkYW4uRmxpbm5AcG9zdGdyYWQubWFuY2hlc3Rlci5hYy51aw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.